Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Austin Lee Resourcing

    Austin Lee Resourcing was founded with a clear sense of purpose to provide a high level service that is efficient, genuine and innovative to both our candidates and our clients. Our objective is to provide informed career advice and opportunities to our candidates and added value to our clients’ global resourcing needs. Our combined expertise in Business Operations, Finance, Healthcare plus Communications helps us deliver this.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    M3 (EU)

    M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

    View Profile

    Digital communications, Medical education, Recruitment and career development

    Company Details

    Austin Lee Resourcing
    North West London, London, N3, United Kingdom
    0208 371 5603
    Contact Austin Lee Resourcing
    Website

     Latest Content from PMHub 

    Louise Verrall from Lucid Group wins Communiqué 2016 Award for Emerging Leader in Healthcare Communications

    Videos and Podcasts | July 13, 2016 | Lucid Group Communications Limited

    From her first degree to her current position as Business Unit Director, Louise has developed a passion for science, education, psychology and entrepreneurialism. She is driven to make a difference...

    Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data

    Videos and Podcasts | July 13, 2016 | Lucid Group Communications Limited

    The winning programme - Treating beyond symptoms in IBD: The Steroid Assessment Tool. Our approach to medical education is really helping to improve patient outcomes and change lives.

    Unlimited wins at Communiqué Awards

    Press Releases | July 11, 2016 | Health Unlimited

    Health Unlimited, Liberation Unlimited and Rock Unlimited all win the judges’ approval.

    Lucid Group shines at the Communiqué Awards

    Press Releases | July 8, 2016 | Lucid Group Communications Limited

    Lucid Group’s commitment to be a leader in medical education was recognised at the Communiqué Awards 2016 in London last night, where the agency received three awards, including being highly...

    What have you learned about your customers recently?

    White Papers and Resources | July 6, 2016 | Anthill Agency

    Your customer-facing staff continually gets told about the needs and wants of your customers. Are you learning what they are learning?

    Infographic: HIV Market Snapshot

    White Papers and Resources | July 6, 2016 | Inizio

    Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently treated with a STR (single...

    Infographic: The vaccine opportunity in Asia

    White Papers and Resources | July 6, 2016 | Inizio

    As predicted, the vaccine market in emerging and developing countries has continued to expand. While the global vaccine market is expected to grow at around 12% annually over the next...

    Webinar: What next for biosimilars?

    White Papers and Resources | July 6, 2016 | Inizio

    Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST

    Understanding the Patient Journey

    White Papers and Resources | July 6, 2016 | Inizio

    The patient journey is changing. Patients are now much more educated and engaged. They have access to information and want to be involved in decisions around their treatment programme.  Technology...

    Case Study: Oncology diagnostic biomarker landscaping study

    White Papers and Resources | July 6, 2016 | Inizio

    The challenge:Our client needed to understand moleculardiagnostic testing growth opportunities for a new biomarker in oncology. They wanted to understand the current market landscape, identify potential leverage points that would maximise use of the biomarker...